Document is current
Any future updates will be listed below
-
Authors
Wang, Xin
Zhang, Ying
Peng, Jie
Zhang, Hua
Jiang, Tingting
Zhang, Zhikang
Yin, Tao
Su, Xun
Zhang, Tao
Shen, Lingchao
He, Shitao
Wang, Xiaolei
Li, Danyang
Yue, Xinyu
Ji, Duoxu
Zhang, Dongyang
Dong, Rui
Zou, Weiwei
Liang, Dan
Liu, Yajing
Du, Yinan
Zhang, Zhiguo
Cao, Yunxia
Liang, Chunmei
Ji, Dongmei
-
Funding
Funding for this research was provided by:
the National Natural Science Foundation of China (NSFC-U20A20350)
the National Natural Science Foundation of China (NSFC-82173532)
the National Natural Science Foundation of China (NSFC-81971455)
the Innovation and Entrepreneurial Projects for Students of Anhui Medical University (S202210366001)
the National Key Research and Development Program of China (2021YFC2700901)
the Excellent Youth Program for Research in Universities of Anhui Education Department (2022AH020072)
the Key Project of Scientific Research Fund of Anhui Institute of Translational Medicine (2021zhyx-B12)
Distinguished Young Scholar Project of Anhui Colleges (gxgnfx2020087)
- License Information
-
More Information
Article History
Received: 21 March 2024
Accepted: 14 May 2024
First Online: 24 May 2024
Declarations
:
: The study was approved granted approval from the Bioethics Committee at the First Affiliated Hospital, Anhui Medical University (No. PJ20220723). All patients received a full explanation of the controlled ovarian hyperstimulation regimen and provided written signed informed consent. Moreover, all donor patients of follicular fluid signed the written informed consent.
: The authors declare that they have no competing interests.
